articleThe Lancet OncologyApr 17, 2013GREEN OA

Capecitabine and cisplatin with or without cetuximab for patients with previously untreated advanced gastric cancer (EXPAND): a randomised, open-label phase 3 trial

FLFlorian LordickYKYoon‐Koo KangHCHyun Cheol ChungPSPamela SalmanSCSang Cheul Oh

Leipzig University of Applied Sciences · Leipzig University · +16 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

838
total citations
FWCI
71.13
Percentile
100%
References
42
Citations per year

Authors

16

Topics & keywords

Topics
Keywords
  • Medicine
  • Capecitabine
  • Cetuximab
  • Internal medicine
  • Clinical endpoint
  • Cancer
  • Population
  • Response Evaluation Criteria in Solid Tumors
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.

Funding